SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-061721
Filing Date
2011-12-22
Accepted
2011-12-22 15:45:01
Documents
1
Period of Report
2011-12-20

Document Format Files

Seq Description Document Type Size
1 GOLDBERG 122011 FORM 4 rrd328811.html 4  
1 GOLDBERG 122011 FORM 4 rrd328811.xml 4 4055
  Complete submission text file 0001181431-11-061721.txt   5533
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 111277419